Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2000
10/18/2000EP1043996A2 Treatment of dyskinesias
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP1043991A1 Treatment for alzheimer's disease
10/18/2000EP1043982A2 Lipase inhibiting polymers
10/18/2000EP1043980A2 Method of reducing craving in mammals
10/18/2000EP1043930A1 Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
10/18/2000EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
10/18/2000EP0823901B1 Quinazoline derivative
10/18/2000CN1270632A APPIL-a novel protein with growth effects
10/18/2000CN1270592A Spiroazabicyclic heterocyclic compounds
10/18/2000CN1270591A Novel compounds
10/18/2000CN1270590A Novel compounds
10/18/2000CN1270589A Epothilone derivatives
10/18/2000CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/18/2000CN1270528A Nootropic agent
10/18/2000CN1270524A Cationic polymers as toxin-binding agents
10/18/2000CN1270519A Anti-first-pass effect compounds
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270517A Antimicrobials
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/18/2000CN1270062A Glycobiazole metal salt as synergist for radiotherapy or chemicotherapy and its preparing process and application
10/18/2000CN1270034A application of coenzyme in histocyte chemistry and prevention and cure of radiation injury
10/18/2000CN1270021A Anhydrous composition for bleaching keratin fibers
10/18/2000CN1270020A Aqueous composition for bleaching keratin fibers instantaneously
10/18/2000CN1057522C Naphthalene derivs. as prostaglandin I2 agonists
10/18/2000CN1057454C Health beautifying wine
10/18/2000CN1057450C Medical liquid and its preparation method
10/18/2000CN1057442C Preparing method for composition pharmaceutique for parenteral injection
10/17/2000US6133460 Have primary amino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen which permit binding to nucleic acid of pathogens; conditions that photoactivate these psoralens result in inactivation of pathogens which contain nucleic acid
10/17/2000US6133458 Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, and methods
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133423 Don-1 gene and polypeptides and uses therefor
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133326 Compositions and methods for decreasing sebum production
10/17/2000US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea
10/17/2000US6133315 Administering to treat pancreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation in a mammal; compounds such as 2-chlorobenzenesulfonic acid 3-(3-amidinopropoxy)-5-methylphenyl ester hydrochloride
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/17/2000US6133304 Treating fibrosis, ventricular dilation, and/or heart failure in a mammal by administering an antifibrotic amount of a mixture of an angiotensin-converting enzyme(ace) inhibitor and at least one matrix metalloproteinase(mmp) inhibitor
10/17/2000US6133302 Kynurenine-3-hydroxylase enzyme inhibitory activity, an enzyme of the kynurenine (kyn) pathway; compounds such as 5-(3-(3-fluorophenyl)-3-oxo-propyl)-1h-tetrazole; for treatment of neuropathological processes
10/17/2000US6133295 Pharmaceutical composition
10/17/2000US6133293 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action; potent depressive effect on diabetic hyperglycemia; 2,4-thiazolidinediones and oxazolidinediones
10/17/2000US6133277 Little or no vasoconstrictor activity; gastrointestinal disorders, e.g. dyspepsia, early satiety, bloating and anorexia; 1-(3-((3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-amino)-propyl)-tetrahydro -2(1h)-primidinone
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133265 Treating physiological disorders associated with an excess of neuropeptide y, such as eating disorders, e.g., obesity, bulimia, and certain cardiovascular diseases, e.g., hypertension
10/17/2000US6133262 3-aminobenzo(b)thiophene derivatives
10/17/2000US6133261 Amino acid derivatives useful to treat stroke
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133255 Useful in the therapy of deleterious mental states; psychological disorders
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6133235 Glucagon-like insulinotropic peptides compositions and methods
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133031 Antisense inhibition of focal adhesion kinase expression
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132758 A loratadine and an aminopolycarboxylic acid or a salt thereof.
10/17/2000US6132754 Injecting said patient with solution of anticholinergic medications containing atropine, scopolamine and chlorpromazine; concomitantly prescribing anticholinergic medications and benzodiazepines
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/17/2000US6132715 Method of inhibiting biosynthesis of tumor necrosis factor
10/17/2000US6132473 Differential treatment of prosthetic devices
10/17/2000US6131567 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2305893A1 Use of maduraphthalazine derivatives as inhibitors of proinflammatory cytokines
10/17/2000CA2192944C Stimulation of hair growth by peptide-copper complexes
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/17/2000CA2156726C Bisacodyl dosage form
10/17/2000CA2074533C 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
10/17/2000CA2024694C Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
10/15/2000CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060098A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus
10/12/2000WO2000059922A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them
10/12/2000WO2000059919A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
10/12/2000WO2000059913A1 Novel thiazolobenzimidazole derivatives
10/12/2000WO2000059912A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
10/12/2000WO2000059909A1 Heterocyclic compounds having affinities for serotonin receptors
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059892A1 Pyrimidine compounds with pharmaceutical activity
10/12/2000WO2000059889A1 α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES
10/12/2000WO2000059887A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000WO2000059876A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059865A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
10/12/2000WO2000059864A1 Lta4 hydrolase inhibitors
10/12/2000WO2000059855A1 Ether compounds, compositions, and uses thereof
10/12/2000WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000WO2000059577A1 Low dose estrogen interrupted hormone replacement therapy
1 ... 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 ... 1564